10
Participants
Start Date
January 31, 2007
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Pegylated Interferon Alpha2b
Weekly subcutaneous injection of 1 microgram/kg/week
Standard care
Standard care
Mayo Clinic, Rochester
Lead Sponsor
Collaborators (1)
Augusta University
OTHER
Unity Health Toronto
OTHER
Schering-Plough
INDUSTRY
Mayo Clinic
OTHER